If you’re still on the fence about voting in this election, think about what really matters – about the values we were taught, the kind of country we want to be, and how this is a moment when your vote really does count.
Your vote could determine the fate of our republic – the world that our children and grandchildren will inherit. It’s an awesome responsibility. But what an extraordinary privilege it is to live in a democracy that gives each of us the opportunity to make our voices heard.
In the shadow of the Trinary, who will you become? EVE Frontier: a space survival simulation, revealed today.
Watch the Teaser Trailer now: https://t.co/UkY1xL6m7f
Learn more and register for the PHASE IV playtest (starts Sept 27) https://t.co/lNH5KZIbZr
#EVEFrontier
Excited to announce our first entrepreneur-in-residence, Andrew Haller, who will help turn #MedicinebyDesign's ground-breaking research into real-world impact. Read more ➡️ https://t.co/KYKmWmJ8WZ
Join Prof. Omar F. Khan (@OFKLab) & Thara Sivasubramaniyam, PhD, from the Robbins lab @TGHRI_UHN, in conversation about their collaboration using nanotechnology to control inflammation. #regenmed
🗓️Thurs., Nov 11, 2 p.m. to 3 p.m.
➡️Register & learn more: https://t.co/Wy5umHwfF6
What to learn about clinical trials? Do you have device or app and wondering if you need a full RCT? (hint: the answer might be no)
Come to a clinical trial lunch and learn co-hosted by CTO, @wchwihv, AHRC, @TOHealthToronto , and @H2i_UofT
https://t.co/8PongJDoHV
@3iOntario
Join #CTO19 and hear a bioethicist, a statistician and a pragmatic clinical trial expert discuss method and ethical challenges in the context of real-world trials in orthopaedic trauma. https://t.co/wkbGuazkE4 #clinicaltrials@rotmanphilo@MacDeptMed@OttawaHospital
Hear how Amazon is applying emerging technologies to improve public health outcomes, including using data to help fight the opioid epidemic from Keynote Michael Jackson @MicJax of @AWScloud#CTO19
Today we announced that @Celgene has invested in a new potential treatment for leukemia developed by OICR researchers. The path to this achievement is a unique, made-in-Ontario story. Read it here: https://t.co/kA75OORaja #cancerresearch#leukemia@thesgconline@FACITca
If all options are exercised the investment could exceed US$1 billion – which would make it the largest transaction to date for a preclinical asset discovered in Canada. News release: https://t.co/3Q2cIXzubM